FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

422456007: ranibizumab (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2007. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
193211000077112 ranibizumab fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Common French translation module (core metadata concept)
2641602015 Ranibizumab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2645708017 Ranibizumab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
469901000077116 ranibizumab (substance) fr Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT Common French translation module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
ranibizumab Has disposition (attribute) Vascular endothelial growth factor receptor antagonist (disposition) true Inferred relationship Some
ranibizumab est un(e) (attribut) Substance with vascular endothelial growth factor receptor antagonist mechanism of action (substance) true Inferred relationship Some
ranibizumab est un(e) (attribut) Monoclonal antibody agent (substance) false Inferred relationship Some
ranibizumab est un(e) (attribut) inhibiteur de l'angiogenèse true Inferred relationship Some
ranibizumab est un(e) (attribut) Monoclonal antibody (substance) true Inferred relationship Some
ranibizumab Has disposition (attribute) Angiogenesis inhibitor (disposition) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Ranibizumab only product a pour principe actif (attribut) True ranibizumab Inferred relationship Some 1
Product containing precisely ranibizumab 10 milligram/1 milliliter conventional release solution for injection (clinical drug) Has basis of strength substance (attribute) True ranibizumab Inferred relationship Some 1
Product containing precisely ranibizumab 10 milligram/1 milliliter conventional release solution for injection (clinical drug) Has precise active ingredient True ranibizumab Inferred relationship Some 1
Ranibizumab-containing product in parenteral dose form a pour principe actif (attribut) True ranibizumab Inferred relationship Some 1
Ranibizumab only product in parenteral dose form a pour principe actif (attribut) True ranibizumab Inferred relationship Some 1
Uveitis due to ranibizumab Causative agent True ranibizumab Inferred relationship Some 1
Product containing ranibizumab (medicinal product) a pour principe actif (attribut) True ranibizumab Inferred relationship Some 1
Ranibizumab 10mg/mL solution for intravitreal injection 0.05mL vial (product) a pour principe actif (attribut) False ranibizumab Inferred relationship Some
Uveitis due to ranibizumab Causative agent False ranibizumab Inferred relationship Some 2

Reference Sets

Canada English language reference set (foundation metadata concept)

Description inactivation indicator reference set

GB English

US English

Back to Start